Perceptive Advisors

Portfolio · 5

Evalon

Protects Enterprises from GenAI-era Human Identity Fraud and Scams

1 round Latest: 2025-01

Insightec

MR-guided Focused Ultrasound Systems

Led ★ 1 round $200.0M committed Latest: 2022-09

DarioHealth

Digital Therapeutics for Treating Chronic Conditions

1 round $70.0M committed Latest: 2021-01

VYNE Therapeutics

Therapies for the Treatment of Immuno-inflammatory Conditions

1 round $64.0M committed Latest: 2019-07

Motus GI

Colon Cleansing for Colonoscopy

1 round $30.0M committed Latest: 2017-02

Investment activity

1 portfolio exit on record.

Q&A

What is Perceptive Advisors' primary investment focus?

Perceptive Advisors primarily focuses on the Health Tech & Life Sciences sector, with all five of its listed portfolio companies operating in this area.

Can you name some of Perceptive Advisors' notable portfolio companies?

Perceptive Advisors' portfolio includes companies such as DarioHealth, which develops digital therapeutics for chronic conditions, and Insightec, known for its MR-guided focused ultrasound systems.

What was a significant exit for Perceptive Advisors?

Perceptive Advisors had an exit in February 2018 when Motus GI went public on NASDAQ. Motus GI focuses on colon cleansing for colonoscopy.

What is the typical investment stage for Perceptive Advisors?

Perceptive Advisors has participated in various funding stages, including D Rounds, Debt Financing, and PIPE rounds.

When did Perceptive Advisors make its most recent investments?

Perceptive Advisors made investments in January 2021 and September 2022, according to startupim data.

What is the total capital raised by Perceptive Advisors' portfolio company Insightec?

Insightec, a Perceptive Advisors portfolio company, has raised a total of $592.9M.

What is the total capital raised by Perceptive Advisors' portfolio company DarioHealth?

DarioHealth, a Perceptive Advisors portfolio company, has raised a total of $244.61M.